Private Equity Firm Other

Astorg

Luxembourg, Luxembourg, Luxembourg

Pan-European private equity firm partnering with management teams to acquire and grow market-leading companies across healthcare, software, technology, business services and technology-based industrial sectors. Headquartered in Luxembourg with offices including London and Paris.

Focus Areas
Healthcare, Software, Technology
Website
astorg.com

Tracked deals

38

38 tracked deals across 2018-2026.

Recent pace

3

3 tracked deals announced in the last 12 months.

Deal mix

Buyout

26 buyout · 6 addon · 4 growth capital

Astorg Acquisition Volume by Year

Last 9 years

Acquisition volume by year Annual acquisition counts for the last 9 years for Astorg. 1 2018 4 2019 3 2020 11 2021 6 2022 2 2023 4 2024 4 2025 ~4 est. 3 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

Showing the 12 most recent of 38 tracked deals for Astorg.

  • Buyer
    Solina USA, Solina Group SAS, Astorg Partners, HC Private Investments LLC (HCPI)
    Target
    Epicurean Butter Co.
    Seller
    HC Private Investments LLC (HCPI), HC Private Investments, HC Private Investments
    Industry
    Food & Beverage
    Type
    Buyout

    Solina USA acquired Epicurean Butter, a Denver-based developer and manufacturer of flavored compound butters and customized dairy flavor solutions. The deal expands Solina’s dairy innovation and flavor development capabilities, with Epicurean continuing to operate from its Denver facility under its existing leadership team.

  • Buyer
    Astorg
    Target
    Thermo Fisher Scientific (Microbiology business unit)
    Seller
    Thermo Fisher Scientific
    Location
    United States
    Type
    Buyout

    Astorg has signed a definitive agreement to acquire Thermo Fisher Scientific’s global microbiology business in a carve-out transaction. The unit will operate as an independent, privately owned platform backed by Astorg, focused on antimicrobial susceptibility testing and microbiology diagnostics. The deal is expected to close in the second half of 2026 (and is later reported as completed in 2026).

  • Buyer
    Solabia, Astorg, TA Associates
    Target
    Mibelle Biochemistry, Seqens' Botanical Actives and In-Vitro Diagnostics Activity, Xebios Group
    Industry
    Biotechnology
    Location
    France
    Type
    Addon

    Solabia, a Paris-headquartered biotech platform focused on natural active ingredients and diagnostics solutions, has agreed to acquire three complementary businesses as part of its international expansion strategy. The acquisitions include Switzerland-based Mibelle Biochemistry, France-based Seqens' Botanical Actives and In-Vitro Diagnostics activity, and Germany/Netherlands-based Xebios Group.

  • Buyer
    Astorg, Sigla
    Target
    ATTIKON Finanz AG
    Industry
    Insurance
    Location
    North Rhine-Westphalia, Germany
    Type
    Buyout

    Astorg, a pan‑European private equity firm, has made an investment in ATTIKON Finanz AG, a leading German commercial insurance brokerage platform. Sigla remains invested alongside the founders and management; Astorg will support ATTIKON's buy‑and‑build strategy, digitization and expansion into MGA and complementary services.

  • Buyer
    Normec, Astorg
    Target
    MS Bio, MJ Reider, NorthEast BioLab
    Seller
    NorthEast BioLab (sold; seller not otherwise specified)
    Industry
    IT Services
    Location
    United States
    Type
    Addon

    Normec, a European testing, inspection, certification, and compliance (TICC) provider, entered the United States by acquiring three specialized laboratories: MS Bio, MJ Reider, and NorthEast BioLab. The acquisitions expand Normec’s addressable market and deepen capabilities across bioanalysis, water quality, and nutritional testing for regulated end markets including healthcare and food-related compliance.

  • Buyer
    Astorg
    Target
    Solabia Group
    Seller
    TA Associates
    Industry
    Biotechnology
    Location
    Île-de-France, France
    Type
    Buyout

    Astorg has signed a definitive agreement to acquire a majority stake in Solabia Group from TA Associates, with TA reinvesting alongside Astorg. Solabia, a Paris-headquartered biotech ingredients manufacturer with 11 production sites, 8 R&D labs and over 900 employees, will partner with Astorg to accelerate international expansion (particularly in the US and Asia), advance product innovation and pursue targeted M&A.

  • Buyer
    Astorg
    Target
    FUJIFILM Irvine Scientific Medical Media Business
    Seller
    FUJIFILM Irvine Scientific
    Industry
    Medical Devices
    Type
    Addon

    Astorg has signed a definitive agreement to acquire FUJIFILM Irvine Scientific's Medical Media Business (Irvine Scientific MBU) from FUJIFILM Irvine Scientific, adding culture and vitrification media products to its recently combined assisted reproductive technology (ART) platform created from Hamilton Thorne and Cook Medical's Reproductive Health business. The deal is an add-on designed to create a global ART MedTech leader by expanding product capabilities for fertility clinics and IVF laboratories; financial terms were not disclosed.

  • Buyer
    Astorg
    Target
    Hamilton Thorne, Cook Medical Reproductive Health
    Seller
    Cook Medical
    Industry
    Medical Devices
    Type
    Buyout

    Astorg completed a take-private of Hamilton Thorne and simultaneously acquired Cook Medical’s Reproductive Health business, combining the two to create a global leader in assisted reproductive technology (ART) consumables, instruments and equipment. The combined company will serve fertility clinics and IVF laboratories in over 115 countries, with a new executive team appointed to lead the integrated MedTech platform.

  • Buyer
    Astorg Mid-Cap (Astorg)
    Target
    Redslim
    Seller
    Eric Bensimon, Alberto Alcaniz, Soren Altmann, Patric Mezei
    Industry
    Data & Analytics
    Location
    Zug, Switzerland
    Type
    Buyout

    Astorg Mid-Cap (Astorg) has signed a binding agreement to acquire a majority stake in Redslim from its founders, who will reinvest significantly. The investment will support Redslim's international expansion, accelerate R&D and platform investments, and scale commercial and service teams to serve CPG and consumer healthcare clients.

  • Buyer
    Astorg
    Target
    Lebronze alloys
    Industry
    Manufacturing
    Location
    France
    Type
    Buyout

    Astorg has entered exclusive negotiations to acquire a majority stake in Lebronze alloys, a France-headquartered global leader in high-performance copper and nickel alloys. The investment would see Lebronze's Executive Chairman Michel Dumont remain a significant shareholder while Astorg supports growth initiatives including geographic expansion (notably the U.S. and India) and downstream service-center rollouts; financial terms were not disclosed.

  • Buyer
    Astorg
    Target
    Steliau
    Seller
    B&Capital
    Location
    France
    Type
    Buyout

    Astorg, a European private equity firm, has signed an agreement to acquire a majority stake in Steliau, a pan-European value-added distributor (VAD) of electronic solutions, from B&Capital. Steliau, founded in 1992 and headquartered in Montrouge, France, employs more than 200 people across eight countries and will partner with Astorg to accelerate organic growth and execute a buy-and-build strategy.

  • Buyer
    Astorg Mid‑Cap, Apheon
    Target
    Sofico
    Industry
    Software
    Location
    East Flanders, Belgium
    Type
    Buyout

    Astorg Mid‑Cap will invest a 51% stake in Sofico in partnership with Sofico founders Gémar Hompes and Piet Maes and existing investor Apheon, with the founders and Apheon significantly reinvesting and remaining involved. Sofico, headquartered in Ghent, is a leading software provider for the automotive leasing and mobility industry, employs over 500 experts, serves major global leasing customers, and will use the partnership to accelerate product development, services expansion and M&A; financial terms were not disclosed and the deal is expected to close in Q1 2024.

Related Acquisition Pages

Selling a company? Get in front of buyers like Astorg

Turn tracked acquisition activity into an outreach-ready buyer list.